Venetoclax to Augment Epigenetic Modification and Chemotherapy
Conditions: Acute Myeloid Leukemia, in Relapse; Acute Myeloid Leukemia Refractory Interventions: Drug: Venetoclax; Drug: Azacitadine; Drug: Vorinostat; Drug: Cytarabine; Drug: Fludarabine; Drug: Filgrastim Sponsor: Medical College of Wisconsin Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials